Tharimmune Market Value
| THARDelisted Stock | 4.95 0.21 4.43% |
| Symbol | Tharimmune |
Tharimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tharimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tharimmune.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Tharimmune on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Tharimmune or generate 0.0% return on investment in Tharimmune over 90 days. Tharimmune is related to or competes with BioLineRx, GeoVax Labs, Adlai Nortye, Lunai Bioworks, SeaStar Medical, Ainos, and Apollomics. More
Tharimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tharimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tharimmune upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.98 | |||
| Information Ratio | 0.1277 | |||
| Maximum Drawdown | 29.73 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 11.15 |
Tharimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tharimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tharimmune's standard deviation. In reality, there are many statistical measures that can use Tharimmune historical prices to predict the future Tharimmune's volatility.| Risk Adjusted Performance | 0.1157 | |||
| Jensen Alpha | 0.7588 | |||
| Total Risk Alpha | 0.5475 | |||
| Sortino Ratio | 0.1341 | |||
| Treynor Ratio | 0.3865 |
Tharimmune February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1157 | |||
| Market Risk Adjusted Performance | 0.3965 | |||
| Mean Deviation | 5.19 | |||
| Semi Deviation | 5.44 | |||
| Downside Deviation | 5.98 | |||
| Coefficient Of Variation | 740.07 | |||
| Standard Deviation | 6.28 | |||
| Variance | 39.41 | |||
| Information Ratio | 0.1277 | |||
| Jensen Alpha | 0.7588 | |||
| Total Risk Alpha | 0.5475 | |||
| Sortino Ratio | 0.1341 | |||
| Treynor Ratio | 0.3865 | |||
| Maximum Drawdown | 29.73 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 11.15 | |||
| Downside Variance | 35.72 | |||
| Semi Variance | 29.61 | |||
| Expected Short fall | (5.85) | |||
| Skewness | (0.17) | |||
| Kurtosis | (0.22) |
Tharimmune Backtested Returns
Tharimmune is very risky given 3 months investment horizon. Tharimmune owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.23, which indicates the firm had a 0.23 % return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.39% are justified by taking the suggested risk. Use Tharimmune Risk Adjusted Performance of 0.1157, coefficient of variation of 740.07, and Semi Deviation of 5.44 to evaluate company specific risk that cannot be diversified away. Tharimmune holds a performance score of 17 on a scale of zero to a hundred. The entity has a beta of 2.17, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tharimmune will likely underperform. Use Tharimmune value at risk, and the relationship between the jensen alpha and skewness , to analyze future returns on Tharimmune.
Auto-correlation | 0.19 |
Very weak predictability
Tharimmune has very weak predictability. Overlapping area represents the amount of predictability between Tharimmune time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tharimmune price movement. The serial correlation of 0.19 indicates that over 19.0% of current Tharimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.69 |
Pair Trading with Tharimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.Moving together with Tharimmune Stock
Moving against Tharimmune Stock
| 0.76 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.7 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.6 | OSE | OSE Pharma SA | PairCorr |
| 0.58 | DRMA | Dermata Therapeutics | PairCorr |
| 0.55 | CDIOW | Cardio Diagnostics | PairCorr |
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Tharimmune Correlation, Tharimmune Volatility and Tharimmune Performance module to complement your research on Tharimmune. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Tharimmune Stock
If you are still planning to invest in Tharimmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tharimmune's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |